Susunod

Auto-play

Progression of Metastatic Pancreatic Cancer

6 Mga view • 07/30/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

George Kim, MD, discusses treatment options for second-line therapy in patients with gemcitabine-refractory pancreatic cancer based on the NCCN guidelines.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play